Christopher A. Viehbacher is joining Biogen Inc. as its President and Chief Executive Officer and a member of the Board of Directors. His appointment will be effective November 14, the company announced. He will be taking over from Michel Vounatsos, who has led the company since 2017.

Stelios Papadopoulos, Ph.D., Chairman of the Board of Biogen, said: “Chris is the rare pharma executive who has a keen understanding of the complexities involved in running a multibillion-dollar global pharma business as well as a deep appreciation for the value of innovation. It was the combination of these attributes that enabled him to turn around Sanofi and leave behind a much better company compared to the one he inherited. I look forward to Chris leading Biogen to the next chapter of its evolution and, on behalf of the board, I pledge our support to his effort.”

Also read | What is Daxxify, the new anti-wrinkle drug?

Viehbacher expressed his excitement about taking up the new role at Biogen. “It is both an honor and an exciting opportunity to join the Biogen team. I greatly admire Biogen for its determination and resilience in pioneering important new medicines to address some of the most difficult and challenging conditions in healthcare. I am inspired by Biogen’s mission and untapped potential and look forward to working with the dedicated Biogen team to build an even stronger company for the benefit of patients, stakeholders and investors,” he said. 

Previously, Viehbacher spent 20 years with GlaxoSmithKline. He has served as the global CEO of Sanofi for six years. Under Viehbacher’s leadership, Sanofi strengthened and diversified its R&D pipeline and also delivered significant value to shareholders.

Also read | Alzheimer’s drugmakers seek quicker FDA approval after US coverage decision

Chris Viehbacher net worth

Chris Viehbacher also previously served as a member of PureTech’s board of directors since 2015 as well as the chairman of the company since September 2019. He is the managing partner of Gurnet Point Capital, a Boston-based investment fund associated with the Bertarelli family. 

As of 2021, he had an estimated net worth of $1 million – $5 million. 

Also read | Medicare limits coverage of $28,000-a-year Alzheimer’s drug

Christopher Viehbacher age 

Christopher Viehbacher was born on March 26, 1960, and is currently 62 years old. 

Christopher Viehbacher relationship

Not much is known about his personal life. Viehbacher is married and has three children.

Christopher Viehbacher family

Christopher Viehbacher holds German and Canadian citizenship. Viehbacher was born in Canada to an English mother and a Bavarian father. His son attended college in Boston and his oldest daughter has pursued a master’s degree from Harvard University.